Passage Bio Statistics Share Statistics Passage Bio has 3.12M
shares outstanding. The number of shares has increased by 0.02%
in one year.
Shares Outstanding 3.12M Shares Change (YoY) 0.02% Shares Change (QoQ) 0% Owned by Institutions (%) 54.45% Shares Floating 2.84M Failed to Deliver (FTD) Shares 2,556 FTD / Avg. Volume 5.47%
Short Selling Information The latest short interest is 108.28K, so 3.47% of the outstanding
shares have been sold short.
Short Interest 108.28K Short % of Shares Out 3.47% Short % of Float 4.71% Short Ratio (days to cover) 1.93
Valuation Ratios The PE ratio is -10.58 and the forward
PE ratio is -0.43.
Passage Bio's PEG ratio is
0.25.
PE Ratio -10.58 Forward PE -0.43 PS Ratio 0 Forward PS 9.2 PB Ratio 11.18 P/FCF Ratio -14.27 PEG Ratio 0.25
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Passage Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.07,
with a Debt / Equity ratio of 0.42.
Current Ratio 4.07 Quick Ratio 4.07 Debt / Equity 0.42 Debt / EBITDA -0.41 Debt / FCF -0.53 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.08M Employee Count 60 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -62.63% in the
last 52 weeks. The beta is 1.81, so Passage Bio's
price volatility has been higher than the market average.
Beta 1.81 52-Week Price Change -62.63% 50-Day Moving Average 7.35 200-Day Moving Average 9.76 Relative Strength Index (RSI) 48.37 Average Volume (20 Days) 46,723
Income Statement
Revenue n/a Gross Profit -3.08M Operating Income -70.4M Net Income -64.77M EBITDA -61.69M EBIT -64.77M Earnings Per Share (EPS) -1.07
Full Income Statement Balance Sheet The company has 37.57M in cash and 25.48M in
debt, giving a net cash position of 12.1M.
Cash & Cash Equivalents 37.57M Total Debt 25.48M Net Cash 12.1M Retained Earnings -659.24M Total Assets 86.01M Working Capital 48.84M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -47.96M
and capital expenditures -34K, giving a free cash flow of -47.99M.
Operating Cash Flow -47.96M Capital Expenditures -34K Free Cash Flow -47.99M FCF Per Share -0.79
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields PASG does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for PASG is $120,
which is 1927% higher than the current price. The consensus rating is "Buy".
Price Target $120 Price Target Difference 1927% Analyst Consensus Buy Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 14, 2025. It was a
backward
split with a ratio of 1:20.
Last Split Date Jul 14, 2025 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -12.34 Piotroski F-Score 1
